Order Article Reprints

Mercke C, Wickart-Johansson G, Sjödin H, Farrajota Neves da Silva P, Alexandersson von Döbeln G, Margolin G, Jonmarker Jaraj S, Carstens H, Berglund A, Lax I, et al. Radiotherapy—Dose Escalated for Large Volume Primary Tumors—And Cetuximab with or without Induction Chemotherapy for HPV Associated Squamous Cell Carcinoma of the Head and Neck—A Randomized Phase II Trial. Cancers. 2023; 15(9):2543. https://doi.org/10.3390/cancers15092543

Mercke, Claes, Gun Wickart-Johansson, Helena Sjödin, Pedro Farrajota Neves da Silva, Gabriella Alexandersson von Döbeln, Gregori Margolin, Sara Jonmarker Jaraj, Hanna Carstens, Anders Berglund, Ingmar Lax, and et al. 2023. "Radiotherapy—Dose Escalated for Large Volume Primary Tumors—And Cetuximab with or without Induction Chemotherapy for HPV Associated Squamous Cell Carcinoma of the Head and Neck—A Randomized Phase II Trial" Cancers 15, no. 9: 2543. https://doi.org/10.3390/cancers15092543

Mercke, C., Wickart-Johansson, G., Sjödin, H., Farrajota Neves da Silva, P., Alexandersson von Döbeln, G., Margolin, G., Jonmarker Jaraj, S., Carstens, H., Berglund, A., Lax, I., Hellström, M., Hammarstedt-Nordenvall, L., & Friesland, S. (2023). Radiotherapy—Dose Escalated for Large Volume Primary Tumors—And Cetuximab with or without Induction Chemotherapy for HPV Associated Squamous Cell Carcinoma of the Head and Neck—A Randomized Phase II Trial. Cancers, 15(9), 2543. https://doi.org/10.3390/cancers15092543